- Patent Title: Acellular pro-tolerogenic compositions and process for making same
-
Application No.: US14414404Application Date: 2013-07-12
-
Publication No.: US10039786B2Publication Date: 2018-08-07
- Inventor: Mark D. Scott , Duncheng Wang , Wendy M. Toyofuku
- Applicant: CANADIAN BLOOD SERVICES
- Applicant Address: CA Ottawa
- Assignee: CANADIAN BLOOD SERVICES
- Current Assignee: CANADIAN BLOOD SERVICES
- Current Assignee Address: CA Ottawa
- Agency: Norton Rose Fulbright US LLP
- Priority: CA2782942 20120712
- International Application: PCT/CA2013/050543 WO 20130712
- International Announcement: WO2014/008608 WO 20140116
- Main IPC: C12N5/00
- IPC: C12N5/00 ; C12N5/02 ; C07H21/02 ; A61K35/17 ; C12N5/0783 ; A61K39/00 ; C12N15/113 ; A61K9/00 ; A61K35/14 ; A61K47/48 ; A61K35/00 ; A61K35/12

Abstract:
This invention relates to pro-tolerogenic preparations capable of increasing the level of regulatory T cells (Treg) and/or decreasing the level of pro-inflammatory T cells (Th17) to induce anergy or immune tolerance. The pro-tolerogenic preparation is enriched in at least one species of miRNAs and is obtained by contacting two allogeneic leukocyte populations wherein at least one of the two populations is modified with a low-immunogenic biocompatible polymer. Acellular pro-tolerogenic compositions, process for making such composition as well as therapeutic uses of such compositions are also provided.
Public/Granted literature
- US20150174168A1 Acellular Pro-Tolerogenic Compositions and Process for Making Same Public/Granted day:2015-06-25
Information query